- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Additional Reimbursement Considerations in Oncology
During this discussion, Scott Gottlieb, MD; Michael Kolodziej, MD; and Ted Okon, MBA, further discuss how various reimbursement models are impacting clinical practice in oncology.
Dr Gottlieb begins by explaining why the CMS stepped in to regulate the practice of medicine by implementing additional rules regarding the provision of oncology products.
Healthcare reform has impacted oncology care in the United States in many ways, including the establishment of oncology medical homes and the implementation of payment reform models, remarks Mr Okon. He also describes differences in drug pricing in the community setting versus the hospital setting, and discusses the so-called drug incentive.
When establishing measures to help improve current healthcare models, various stakeholders should collaborate and discuss opportunities for achieving optimal efficiency, suggests Mr Okon. Stakeholders also need to work together to improve the reimbursement model for oncology services.
Health Equity & Access Weekly Roundup: November 23, 2024
November 23rd 2024Americans are underinsured, even with employer-based health plans; a thorough critique of the lack of representation among Black patients in clinical trials showcases a persistent theme; systemic barriers in cardiology, breast cancer, and patent systems are examined.
Read More
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
November 21st 2024A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.
Read More
